scholarly journals Degradation of .BETA.-lactamase inhibitor (2S,3R,5S)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-yl-methyl)-4-thia-1-azabicyclo(3.2.0)-heptane-2-carboxylic acid 4,4-dioxide(YTR-830H) in the solid state. Structural elucidation.

1988 ◽  
Vol 36 (11) ◽  
pp. 4593-4596 ◽  
Author(s):  
EIJI MATSUSHIMA ◽  
KEN-ICHIRO YOSHIDA ◽  
RYOTARO AZUMA ◽  
YOSHINORI MINAMI ◽  
TERUYOSHI MARUNAKA
Keyword(s):  
Solid State ◽  
Carboxylic Acid ◽  
Structural Elucidation ◽  
Beta Lactamase ◽  
Lactamase Inhibitor

scholarly journals Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam.

1997 ◽  
Vol 41 (4) ◽  
pp. 721-727 ◽  
Author(s):  
P D Lister ◽  
A M Prevan ◽  
C C Sanders
Keyword(s):  
Antibacterial Activity ◽  
Critical Concentration ◽  
Specific Inhibitor ◽  
Logarithmic Phase ◽  
Critical Ratio ◽  
Beta Lactamase ◽  
Beta Lactam ◽  
Dosing Regimens ◽  
Lactamase Inhibitor

An in vitro pharmacokinetic model was used to study the pharmacodynamics of piperacillin-tazobactam and piperacillin-sulbactam against gram-negative bacilli producing plasmid-encoded beta-lactamases. Logarithmic-phase cultures were exposed to peak antibiotic concentrations observed in human serum after the administration of intravenous doses of 3 g of piperacillin and 0.375 g of tazobactam or 0.5 g of sulbactam. Piperacillin and inhibitor were either dosed simultaneously or piperacillin was dosed sequentially 0.5 h after dosing with the inhibitor. In studies with all four test strains, the pharmacodynamics observed after simultaneous dosing were similar to those observed with the sequential regimen. Since the ratio between piperacillin and tazobactam was in constant fluctuation after sequential dosing, these data suggest that the pharmacodynamics of the piperacillin-inhibitor combinations were not dependent upon maintenance of a critical ratio between the components. Furthermore, when regrowth was observed, the time at which bacterial counts began to increase was similar between the simultaneous and sequential dosing regimens. Since the pharmacokinetics of the inhibitors were the same for all regimens, these data suggest that the length of time that the antibacterial activity was maintained over the dosing interval with these combinations was dictated by the pharmacokinetics of the beta-lactamase inhibitor in the combination. The antibacterial activity of the combination appeared to be lost when the amount of inhibitor available fell below some critical concentration. This critical concentration varied depending upon the type and amount of enzyme produced, as well as the specific inhibitor used. These results indicate that the antibacterial activity of drug-inhibitor combinations, when dosed at their currently recommended ratios, is more dependent on the pharmacokinetics of the inhibitor than on those of the beta-lactam drug.

A MOF based on a lead(II) 2-oxido-6-methylpyridine-4-carboxylate network

2020 ◽  
Vol 75 (4) ◽  
pp. 365-369
Author(s):  
Long Tang ◽  
Yu Pei Fu ◽  
Na Cui ◽  
Ji Jiang Wang ◽  
Xiang Yang Hou ◽  
...  
Keyword(s):  
Crystal Structure ◽  
Solid State ◽  
Carboxylic Acid ◽  
Thermogravimetric Analysis ◽  
Metal Organic Framework ◽  
X Ray Diffraction ◽  
X Ray ◽  
Connected Node ◽  
Metal Organic ◽  
Solid State Fluorescence

AbstractA new metal-organic framework, [Pb(hmpcaH)2]n (1), has been hydrothermally synthesized from Pb(OAc)2 · 3H2O and 2-hydroxy-6-methylpyridine-4-carboxylic acid (hmpcaH2; 2), and characterized by IR spectroscopy, elemental and thermogravimetric analysis, and single-crystal X-ray diffraction. In complex 1, each hmpcaH− ligand represents a three-connected node to combine with the hexacoordinated Pb(II) ions, generating a 3D binodal (3,6)-connected ant network. The crystal structure of 2 was determined. The solid-state fluorescence properties of 1 and 2 were investigated.

Orally effective acid prodrugs of the .beta.-lactamase inhibitor sulbactam

1990 ◽  
Vol 33 (1) ◽  
pp. 344-347 ◽  
Author(s):  
Arthur R. English ◽  
Dennis Girard ◽  
V. John Jasys ◽  
Robert J. Martingano ◽  
Michael S. Kellogg
Keyword(s):  
Beta Lactamase ◽  
Lactamase Inhibitor

scholarly journals Electrochemiluminescence Study of Europium (III) Complex with Coumarin3-Carboxylic Acid

2008 ◽  
Vol 2008 ◽  
pp. 1-6 ◽  
Author(s):  
Stefan Lis ◽  
Krzysztof Staninski ◽  
Tomasz Grzyb
Keyword(s):  
Aqueous Solution ◽  
Spectral Analysis ◽  
Energy Transfer ◽  
Solid State ◽  
Carboxylic Acid ◽  
Elemental Analysis ◽  
Aluminium Electrode ◽  
The Eu

The europium (III) complex of coumarin-3-carboxylic acid (C3CA) has been prepared and characterized on the basis of elemental analysis, IR, and emission (photoluminescence and electrochemiluminescence) spectroscopy. The synthesised complex having a formula Eu was photophysically characterized in solution and in the solid state. Electrochemiluminescence, ECL, of the system containing the Eu(III)/C3CA complex was studied using an oxide-covered aluminium electrode. The goal of these studies was to show the possibility of the use of electrochemical excitation of the Eu(III) ion in aqueous solution for emission generation. The generated ECL emission was very weak, and therefore its measurements and spectral analysis were carried out with the use of cut-off filters method. The studies proved a predominate role of the ligand-to-metal energy transfer (LMET) in the generated ECL.

Sign in / Sign up

Export Citation Format

Share Document